Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anetta Undas

Showing results (411-420 of 652) with videos related to

Pageof 66
Sort By:
Journal of Clinical Medicine|July 2, 2020
Delayed Thrombin Generation Is Associated with Minor Bleedings in Venous Thromboembolism Patients on Rivaroxaban: Usefulness of Calibrated Automated ThrombographyJaroslaw Zalewski, Konrad Stepien, Karol Nowak, et al.
Polish Archives of Internal Medicine|September 30, 2021
Current treatment challenges in the COVID-19 pandemicFilippo Patrucco, Francesco Gavelli, Sharmila Fagoonee, et al.
Polish Archives of Internal Medicine|October 21, 2025
Altered fibrin clot properties and the risk of thromboembolism in women with obstetric antiphospholipid syndrome: a cohort studyMagdalena Piróg, Michał Ząbczyk, Joanna Natorska, et al.
Polish Archives of Internal Medicine|September 26, 2024
High-dose atorvastatin and rosuvastatin reduce the levels of neutrophil extracellular trap-related proteins in coronary artery disease: association with prothrombotic stateKonrad Stępień, Joanna Natorska, Michał Ząbczyk, et al.
Thrombosis and Haemostasis|September 6, 2006
Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemiaAnetta Undas, Ewa Stepień, Rafal Glowacki, et al.
Thrombosis Research|June 15, 2020
Acceptance of a potential major bleeding among patients with venous thromboembolism on long-term oral anticoagulation: the knowledge of the disease and therapy mattersMałgorzata Konieczyńska, Robert W Kupis, Piotr Bijak, et al.
Stroke|May 8, 2004
Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosisAnetta Undas, Joanna Perła, Mariusz Lacinski, et al.
Thrombosis and Haemostasis|February 16, 2005
Antibodies to N-homocysteinylated albumin as a marker for early-onset coronary artery disease in menAnetta Undas, Milosz Jankowski, Magdalena Twardowska, et al.
Thrombosis and Haemostasis|June 10, 2011
Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow)Magdalena Celinska-Lowenhoff, Teresa Iwaniec, Martine Alhenc-Gelas, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|October 16, 2015
CYP2C9 Polymorphism and Unstable Anticoagulation with Warfarin in Patients Within the First 3 Months Following Heart Valve ReplacementEwa Wypasek, Marek Cieśla, Bogdan Suder, et al.
Pageof 66

Showing results (411-420 of 652) with videos related to

Sort By:
Pageof 66
Journal of Clinical Medicine|July 2, 2020
Delayed Thrombin Generation Is Associated with Minor Bleedings in Venous Thromboembolism Patients on Rivaroxaban: Usefulness of Calibrated Automated ThrombographyJaroslaw Zalewski, Konrad Stepien, Karol Nowak, et al.
Polish Archives of Internal Medicine|September 30, 2021
Current treatment challenges in the COVID-19 pandemicFilippo Patrucco, Francesco Gavelli, Sharmila Fagoonee, et al.
Polish Archives of Internal Medicine|October 21, 2025
Altered fibrin clot properties and the risk of thromboembolism in women with obstetric antiphospholipid syndrome: a cohort studyMagdalena Piróg, Michał Ząbczyk, Joanna Natorska, et al.
Polish Archives of Internal Medicine|September 26, 2024
High-dose atorvastatin and rosuvastatin reduce the levels of neutrophil extracellular trap-related proteins in coronary artery disease: association with prothrombotic stateKonrad Stępień, Joanna Natorska, Michał Ząbczyk, et al.
Thrombosis and Haemostasis|September 6, 2006
Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemiaAnetta Undas, Ewa Stepień, Rafal Glowacki, et al.
Thrombosis Research|June 15, 2020
Acceptance of a potential major bleeding among patients with venous thromboembolism on long-term oral anticoagulation: the knowledge of the disease and therapy mattersMałgorzata Konieczyńska, Robert W Kupis, Piotr Bijak, et al.
Stroke|May 8, 2004
Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosisAnetta Undas, Joanna Perła, Mariusz Lacinski, et al.
Thrombosis and Haemostasis|February 16, 2005
Antibodies to N-homocysteinylated albumin as a marker for early-onset coronary artery disease in menAnetta Undas, Milosz Jankowski, Magdalena Twardowska, et al.
Thrombosis and Haemostasis|June 10, 2011
Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow)Magdalena Celinska-Lowenhoff, Teresa Iwaniec, Martine Alhenc-Gelas, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|October 16, 2015
CYP2C9 Polymorphism and Unstable Anticoagulation with Warfarin in Patients Within the First 3 Months Following Heart Valve ReplacementEwa Wypasek, Marek Cieśla, Bogdan Suder, et al.
Pageof 66